Sintx Technologies (NASDAQ:SINT) Given “Buy” Rating at Maxim Group

Sintx Technologies (NASDAQ:SINT)‘s stock had its “buy” rating reiterated by equities researchers at Maxim Group in a report released on Thursday,Benzinga reports. They presently have a $6.00 price objective on the stock. Maxim Group’s price objective would suggest a potential upside of 169.66% from the company’s previous close.

Several other brokerages have also commented on SINT. Ascendiant Capital Markets decreased their target price on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating for the company in a research report on Wednesday, April 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research note on Tuesday, April 21st. Finally, HC Wainwright reissued a “buy” rating and set a $10.00 price objective on shares of Sintx Technologies in a research report on Wednesday, May 20th. Three research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $9.33.

Sintx Technologies Stock Down 0.7%

Shares of NASDAQ SINT traded down $0.02 during midday trading on Thursday, reaching $2.23. The company had a trading volume of 39,755 shares, compared to its average volume of 41,983. The stock has a market cap of $9.61 million, a PE ratio of -0.44 and a beta of 0.66. Sintx Technologies has a one year low of $1.86 and a one year high of $6.78. The firm’s fifty day moving average price is $2.43 and its 200-day moving average price is $3.02.

Sintx Technologies (NASDAQ:SINT) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.66) by ($0.04). The firm had revenue of $0.38 million for the quarter, compared to the consensus estimate of $0.30 million. Sintx Technologies had a negative net margin of 1,058.60% and a negative return on equity of 366.49%. As a group, equities research analysts expect that Sintx Technologies will post -2.22 EPS for the current year.

Institutional Trading of Sintx Technologies

A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC increased its stake in Sintx Technologies, Inc. (NASDAQ:SINT) by 53.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 26,624 shares of the company’s stock after purchasing an additional 9,265 shares during the quarter. Geode Capital Management LLC owned 0.72% of Sintx Technologies worth $103,000 at the end of the most recent quarter. 18.38% of the stock is currently owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.